SLNO Stock-Based Compensation
Soleno Therapeutics Inc · Stock-Based Compensation
SLNO Stock-Based Compensation
Latest reported$21.17Mperiod ending
SLNO TTM Stock-Based Comp ($38.42K → $21.17M)
TTM stock-based compensation
High-resolution chart · PNG
SLNO stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 21,169,000 | |
| 35,848,000 | |
| 54,132,000 | |
| 110,730,000 | |
| 108,192,000 | |
| 99,958,000 | |
| 72,112,000 | |
| 17,715,000 | |
| 11,759,000 | |
| 5,945,000 | |
| 4,668,000 | |
| 3,150,000 | |
| 2,517,000 | |
| 2,530,000 | |
| 2,316,000 | |
| 2,539,000 | |
| 2,825,000 | |
| 3,276,000 | |
| 3,251,000 | |
| 2,719,000 | |
| 2,203,000 | |
| 1,500,000 | |
| 1,402,000 | |
| 1,181,000 | |
| 1,015,000 | |
| 825,000 | |
| 787,000 | |
| 845,000 | |
| 849,000 | |
| 988,000 | |
| 756,031 | |
| 772,031 | |
| 1,036,031 | |
| 880,031 | |
| 1,166,270 | |
| 1,145,270 | |
| 920,270 | |
| 871,270 | |
| 756,369 | |
| 694,369 | |
| 677,369 | |
| 942,369 | |
| 1,070,435 | |
| 931,217 | |
| 734,943 | |
| 345,435 | |
| 24,417 | |
| 23,593 | |
| 22,315 | |
| 38,417 |